Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anil Lakhani"'
Publikováno v:
Hematology. 12:159-162
The diagnosis of mixed-type autoimmune haemolytic anaemia (AIHA) is based on demonstrating the presence of "warm" IgG auto-antibody and "low titre" (64 at 4 degrees C), "high thermal amplitude" (reacting at or30 degrees C) "cold" IgM auto-antibody. M
Autor:
Peter H. Mackie, Rajeev Joshi, Anil Lakhani, Daniel Catovsky, Janet E. Ropner, Andrew G. Bosanquet, Estella Matutes, Henri Grech, Stella J. Bowcock, Patrick D Thornton, Ian D. C. Douglas
Publikováno v:
Annals of Hematology. 82:759-765
Abnormalities of the p53 gene are known to confer detrimental effects in chronic lymphocytic leukaemia (CLL) and are associated with short survival. We have used high dose methylprednisolone (HDMP) to treat 25 patients with advanced refractory CLL of
Autor:
Peter R. E. Johnson, Margaret Cook, Anil Lakhani, Patrick Carrington, Daniel Catovsky, Richard Kaczmarski, Ranjit V Thomas, Isabel Ribeiro, Patricia Shepherd
Publikováno v:
British Journal of Haematology. 116:341-345
Chronic lymphocytic leukaemia (CLL) is a B-cell disorder, which has a median survival of over 10 years from diagnosis for stage A disease. The natural history of stage A disease is generally indolent or only slowly progressive. It is less well known
Publikováno v:
BMJ. 320:1236-1239
Objective: To determine whether trial efficacy of prophylaxis with warfarin for patients with atrial fibrillation at high risk of stroke translates into effectiveness in clinical practice. Design: Two year prospective cohort study. Setting: District
Autor:
Ranjit, Thomas, Isabel, Ribeiro, Patricia, Shepherd, Peter, Johnson, Margaret, Cook, Anil, Lakhani, Richard, Kaczmarski, Patrick, Carrington, Daniel, Catovsky
Publikováno v:
British journal of haematology. 116(2)
Chronic lymphocytic leukaemia (CLL) is a B-cell disorder, which has a median survival of over 10 years from diagnosis for stage A disease. The natural history of stage A disease is generally indolent or only slowly progressive. It is less well known
Autor:
Biju Krishnan, Antonio Parreira, John Swansbury, Anil Lakhani, Robin M. Ireland, Saad M. B. Rassam, Estella Matutes, Daniel Catovsky, Claire Dearden, Bruno Cazin, Nicolas Ketterer
Publikováno v:
Blood. 106:1127-1127
T-PLL is a rare aggressive malignancy with poor response to conventional chemotherapy. In our previously published data on a series of mostly relapsed refractory disease patients treated with the anti CD 52 monoclonal antibody Campath -1H (alemtuzuma
Autor:
Richard M Evans, Elliott Simpson, LG Shankara Rao, J Christine Rodger, Anil Lakhani, William Wilkie
Publikováno v:
Annals of clinical biochemistry. 17(1)
A patient was admitted to a district general hospital within an hour of ingesting a fatal dose of sodium fluoride. The results of laboratory investigations, together with some in vitro findings, support the hypothesis that the hypocalcaemia of fluori
Autor:
Jennifer Maitland, Garry Forgeson, Glen Goss, Ray Powles, Timothy J. Perren, Martin Gore, Sarah Milan, Jennifer Treleaven, A Nandi, Fulvio Porta, Ayed Zuiable, Anil Lakhani
Publikováno v:
Cancer chemotherapy and pharmacology. 23(6)
A total of 65 patients under the age of 55 with acute leukaemia received high-dose cytosine arabinoside (Ara-C) in combination with high-dose etoposide without an anthracycline. Complete remission rates for patients with relapsed or refractory acute